Drawing for Serial No. 79167319

USPTO serial 79167319

Serial No. 79167319

Reviewed by CopyMark Law Group

Reg. 4966827Status 706Renewal
Filing date
Status date
Registration date
May 31, 2016
Examiner
BRADLEY, EVELYN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with Serial No. 79167319?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey L. Costellia

Jeffrey L. Costellia Nixon Peabody LLP799 9TH STREET, N.W., SUITE 500WASHINGTON, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, ] neurological [, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders [ ; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction ]ACTIVE—
042Testing, inspection or research of pharmaceuticals; research of pharmaceutical preparations and medicines for others; conducting clinical trials for others in the field of pharmaceutical products; laboratory research services relating to pharmaceuticals; pharmaceutical product evaluationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 26, 202671AGREGISTERED-SEC.71 ACCEPTED—
Aug 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 19, 2026ES71TEAS SECTION 71 RECEIVED—
Apr 23, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 1, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 27, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Dec 2, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Dec 2, 2022C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Nov 8, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 31, 2022ES75TEAS SECTION 71 & 15 RECEIVED—
May 31, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 8, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 30, 2016CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 25, 2016CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 16, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 31, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 31, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 31, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 31, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 15, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2016GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Feb 2, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 2, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 2, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 14, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 1, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 1, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 1, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 28, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2015ALIEASSIGNED TO LIE—
Oct 9, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 30, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2015RFNTREFUSAL PROCESSED BY IB—
Jun 30, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 29, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 29, 2015RFRRREFUSAL PROCESSED BY MPU—
Jun 28, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 27, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2015DOCKASSIGNED TO EXAMINER—
Jun 25, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 18, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance